Injective (INJ) is currently trading at $3.28, showing a slight decline of 0.50% over the last 24 hours. The price fluctuation for the day has been between a high of $3.49 and a low of $3.12, indicating a daily range of 0.37%, which suggests limited volatility.

Trading volume stands at 164,315,051, representing a 50.17% volume-to-market cap ratio, signaling robust trading activity relative to its overall market size. The hourly moving averages indicate a bullish sentiment, particularly with the 55 SMA at $3.18 showing a gain of 3.03%, while the 1-hour RSI at 54 suggests neutral momentum.

The 7-day RSI at 51 indicates that the asset is neither overbought nor oversold, while the 7-day price change of 8.74% reflects recent positive momentum. However, the 30-day price change of -28.73% highlights significant downward pressure over a longer period, indicating potential resistance levels.

Injective's all-time high of $52.62, reached in March 2024, presents a significant long-term resistance point, with current prices far below this level. As the market seeks direction, the short-term bullish signals from moving averages contrast with the longer-term bearish trend seen in the 30-day price performance.

Considering the mixed signals from technical indicators and the overall downward trend in the 30-day timeframe, the recommendation for Injective (INJ) is to Hold. This strategy allows investors to monitor potential bullish reversals while avoiding immediate exposure to longer-term downward risks.